Published in Prostate on January 17, 2014
Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer. Prostate Cancer Prostatic Dis (2014) 1.74
Irreversible electroporation: just another form of thermal therapy? Prostate (2014) 1.71
Dose-dependent ATP depletion and cancer cell death following calcium electroporation, relative effect of calcium concentration and electric field strength. PLoS One (2015) 1.46
A numerical investigation of the electric and thermal cell kill distributions in electroporation-based therapies in tissue. PLoS One (2014) 1.05
The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol. BMJ Open (2014) 1.03
Focal irreversible electroporation for prostate cancer: functional outcomes and short-term oncological control. Prostate Cancer Prostatic Dis (2015) 0.93
The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients. World J Urol (2015) 0.91
A prospective development study investigating focal irreversible electroporation in men with localised prostate cancer: Nanoknife Electroporation Ablation Trial (NEAT). Contemp Clin Trials (2014) 0.90
MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy. Eur Radiol (2015) 0.87
Mitigation of impedance changes due to electroporation therapy using bursts of high-frequency bipolar pulses. Biomed Eng Online (2015) 0.86
Electric Ablation with Irreversible Electroporation (IRE) in Vital Hepatic Structures and Follow-up Investigation. Sci Rep (2015) 0.83
Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate Cancer. J Urol (2016) 0.82
Calcium Electroporation: Evidence for Differential Effects in Normal and Malignant Cell Lines, Evaluated in a 3D Spheroid Model. PLoS One (2015) 0.81
Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial. BMC Cancer (2016) 0.81
Why we should not routinely apply irreversible electroporation as an alternative curative treatment modality for localized prostate cancer at this stage. World J Urol (2016) 0.78
Improving cancer therapies by targeting the physical and chemical hallmarks of the tumor microenvironment. Cancer Lett (2015) 0.76
Technical and practical considerations for device selection in locoregional ablative therapy. Semin Intervent Radiol (2014) 0.76
Comparison of ablation defect on MR imaging with computer simulation estimated treatment zone following irreversible electroporation of patient prostate. Springerplus (2016) 0.75
Asymmetric Waveforms Decrease Lethal Thresholds in High Frequency Irreversible Electroporation Therapies. Sci Rep (2017) 0.75
Effect of calcium electroporation in combination with metformin in vivo and correlation between viability and intracellular ATP level after calcium electroporation in vitro. PLoS One (2017) 0.75
Enhancing Irreversible Electroporation by Manipulating Cellular Biophysics with a Molecular Adjuvant. Biophys J (2017) 0.75
Irreversible electroporation for the treatment of localized prostate cancer: a summary of imaging findings and treatment feedback. Diagn Interv Radiol (2017) 0.75
Irreversible electroporation-mediated shRNA knockdown of the HPV18 E6 gene suppresses cervical cancer growth in vitro and in vivo. Oncol Lett (2017) 0.75
Minimally invasive lateral approach for symptomatic thoracic disc herniation: initial multicenter clinical experience. J Neurosurg Spine (2011) 2.97
Achieving equal standards in medical student education: is a national exit examination the answer? Med J Aust (2005) 2.78
Tumor ablation with irreversible electroporation. PLoS One (2007) 2.66
Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol (2011) 2.55
In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng (2006) 2.34
Activation of thymic regeneration in mice and humans following androgen blockade. J Immunol (2005) 2.31
Irreversible electroporation: a new challenge in "out of operating theater" anesthesia. Anesth Analg (2010) 2.22
Nonthermal irreversible electroporation for intracranial surgical applications. Laboratory investigation. J Neurosurg (2010) 1.78
microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma. Mol Syst Biol (2010) 1.69
Recovery from anthracycline cardiomyopathy after long-term support with a continuous flow left ventricular assist device. J Heart Lung Transplant (2009) 1.58
Urethral strictures following high-dose-rate brachytherapy for prostate cancer: analysis of risk factors. Brachytherapy (2012) 1.54
Selective isolation of live/dead cells using contactless dielectrophoresis (cDEP). Lab Chip (2010) 1.51
Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study. Int J Cardiol (2010) 1.48
What to do for prostate cancer patients with a rising PSA?--A survey of Australian practice. Int J Radiat Oncol Biol Phys (2003) 1.48
Successful treatment of a large soft tissue sarcoma with irreversible electroporation. J Clin Oncol (2011) 1.48
Australian & New Zealand Faculty of Radiation Oncology Genito-Urinary Group: 2011 consensus guidelines for curative radiotherapy for urothelial carcinoma of the bladder. J Med Imaging Radiat Oncol (2012) 1.45
Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011. Med J Aust (2013) 1.43
Total leukocyte control for elective coronary bypass surgery does not improve short-term outcome. Ann Thorac Surg (2005) 1.43
Mathematical modeling of irreversible electroporation for treatment planning. Technol Cancer Res Treat (2007) 1.37
Lower urinary tract injuries following blunt trauma: a review of contemporary management. Rev Urol (2011) 1.35
A review of basic to clinical studies of irreversible electroporation therapy. IEEE Trans Biomed Eng (2015) 1.31
Age dependency of cartilage magnetic resonance imaging T2 relaxation times in asymptomatic women. Arthritis Rheum (2004) 1.28
Isolation of prostate tumor initiating cells (TICs) through their dielectrophoretic signature. Lab Chip (2011) 1.27
Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting. PLoS One (2011) 1.26
Contactless dielectrophoresis: a new technique for cell manipulation. Biomed Microdevices (2009) 1.23
An insulator-based (electrodeless) dielectrophoretic concentrator for microbes in water. J Microbiol Methods (2005) 1.18
A parametric study delineating irreversible electroporation from thermal damage based on a minimally invasive intracranial procedure. Biomed Eng Online (2011) 1.17
Intracranial nonthermal irreversible electroporation: in vivo analysis. J Membr Biol (2010) 1.15
Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode. Breast Cancer Res Treat (2010) 1.14
Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group. Radiother Oncol (2008) 1.12
Cardiac surgery in patients with a history of malignancy: increased complication rate but similar mortality. Heart Lung Circ (2012) 1.11
Childhood asthma and measles vaccine response. Ann Allergy Asthma Immunol (2006) 1.09
The feasibility of irreversible electroporation for the treatment of breast cancer and other heterogeneous systems. Ann Biomed Eng (2009) 1.09
17q12-21 variants interact with smoke exposure as a risk factor for pediatric asthma but are equally associated with early-onset versus late-onset asthma in North Americans of European ancestry. J Allergy Clin Immunol (2009) 1.06
Experimental characterization and numerical modeling of tissue electrical conductivity during pulsed electric fields for irreversible electroporation treatment planning. IEEE Trans Biomed Eng (2012) 1.06
High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction. Biomed Eng Online (2011) 1.05
Coronary CT angiography versus intravascular ultrasound for estimation of coronary stenosis and atherosclerotic plaque burden: a meta-analysis. J Cardiovasc Comput Tomogr (2013) 1.03
Selective concentration of human cancer cells using contactless dielectrophoresis. Electrophoresis (2011) 1.02
Dielectrophoretic differentiation of mouse ovarian surface epithelial cells, macrophages, and fibroblasts using contactless dielectrophoresis. Biomicrofluidics (2012) 1.02
Ferritin as an indicator of suspected iron deficiency in children with autism spectrum disorder: prevalence of low serum ferritin concentration. Dev Med Child Neurol (2006) 1.00
Theoretical considerations of tissue electroporation with high-frequency bipolar pulses. IEEE Trans Biomed Eng (2010) 1.00
High-dose-rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer. Brachytherapy (2009) 0.97
A randomised, double-blind, placebo-controlled trial of nightly sildenafil citrate to preserve erectile function after radiation treatment for prostate cancer. J Med Imaging Radiat Oncol (2012) 0.96
Modeling and development of a low frequency contactless dielectrophoresis (cDEP) platform to sort cancer cells from dilute whole blood samples. Biosens Bioelectron (2011) 0.96
Massage therapy for cardiac surgery patients--a randomized trial. J Thorac Cardiovasc Surg (2012) 0.95
A preliminary study to delineate irreversible electroporation from thermal damage using the arrhenius equation. J Biomech Eng (2009) 0.94
Extracorporeal membrane oxygenation after lung transplantation: evolving technique improves outcomes. Ann Thorac Surg (2004) 0.93
Both pretreatment prostate-specific antigen level and posttreatment biochemical failure are independent predictors of overall survival after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2004) 0.91
Sample concentration and impedance detection on a microfluidic polymer chip. Biomed Microdevices (2008) 0.90
Towards the creation of decellularized organ constructs using irreversible electroporation and active mechanical perfusion. Biomed Eng Online (2010) 0.90
Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients. Cancer (2004) 0.90
Effect of radiotherapy volume and dose on secondary cancer risk in stage I testicular seminoma. Int J Radiat Oncol Biol Phys (2007) 0.90
Impedimetric and optical interrogation of single cells in a microfluidic device for real-time viability and chemical response assessment. Biosens Bioelectron (2007) 0.90
In vivo irreversible electroporation kidney ablation: experimentally correlated numerical models. IEEE Trans Biomed Eng (2014) 0.90
Positive surgical margins: rate, contributing factors and impact on further treatment: findings from the Prostate Cancer Registry. BJU Int (2014) 0.89
Long-term outcomes from bronchoscopic lung volume reduction using a bronchial prosthesis. Respirology (2011) 0.89
The Prostate Cancer Registry: monitoring patterns and quality of care for men diagnosed with prostate cancer. BJU Int (2012) 0.89
Contactless dielectrophoretic spectroscopy: examination of the dielectric properties of cells found in blood. Electrophoresis (2011) 0.89
The effects of metallic implants on electroporation therapies: feasibility of irreversible electroporation for brachytherapy salvage. Cardiovasc Intervent Radiol (2013) 0.88
Effect of intensity-modulated pelvic radiotherapy on second cancer risk in the postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys (2009) 0.88
A positive response to a recruitment maneuver with PEEP titration in patients with ARDS, regardless of transient oxygen desaturation during the maneuver. J Intensive Care Med (2011) 0.88
A three-dimensional in vitro tumor platform for modeling therapeutic irreversible electroporation. Biophys J (2012) 0.88
Label-free isolation and enrichment of cells through contactless dielectrophoresis. J Vis Exp (2013) 0.88
Functionally distinct PI 3-kinase pathways regulate myelination in the peripheral nervous system. J Cell Biol (2014) 0.87
A randomized, double-blind, placebo-controlled study of preemptive oral oxycodone with morphine patient-controlled anesthesia for postoperative pain management in patients undergoing uterine artery embolization for symptomatic uterine fibroids. Cardiovasc Intervent Radiol (2014) 0.87
Comparison of manual vs. automated multimodality (CT-MRI) image registration for brain tumors. Med Dosim (2005) 0.86
Pilot study of irreversible electroporation for intracranial surgery. Conf Proc IEEE Eng Med Biol Soc (2009) 0.86
Subgenual anterior cingulate cortex activity covariation with cardiac vagal control is altered in depression. J Affect Disord (2013) 0.86
Mitigation of impedance changes due to electroporation therapy using bursts of high-frequency bipolar pulses. Biomed Eng Online (2015) 0.86
An international multicenter study evaluating the impact of an alternative biochemical failure definition on the judgment of prostate cancer risk. Int J Radiat Oncol Biol Phys (2006) 0.85
Joule heating effects on particle immobilization in insulator-based dielectrophoretic devices. Electrophoresis (2013) 0.85
Phrenic nerve injury during cardiac surgery: mechanisms, management and prevention. Heart Lung Circ (2013) 0.85
Effect of preprocedural statin use on procedural myocardial infarction and major cardiac adverse events in percutaneous coronary intervention: a meta-analysis. J Invasive Cardiol (2008) 0.85
Factors predicting for urinary morbidity following 125iodine transperineal prostate brachytherapy. Radiother Oncol (2004) 0.85
Prostate-specific antigen bounce after permanent iodine-125 prostate brachytherapy--an Australian analysis. Int J Radiat Oncol Biol Phys (2010) 0.85
A reinforced sternal wiring technique for transverse thoracosternotomy closure in bilateral lung transplantation: from biomechanical test to clinical application. J Thorac Cardiovasc Surg (2007) 0.84
Development of a microarray platform for FFPET profiling: application to the classification of human tumors. J Transl Med (2009) 0.84
What defines intermediate-risk prostate cancer? Variability in published prognostic models. Int J Radiat Oncol Biol Phys (2004) 0.84
Multilayer contactless dielectrophoresis: theoretical considerations. Electrophoresis (2012) 0.84
Experimental characterization of intrapulse tissue conductivity changes for electroporation. Conf Proc IEEE Eng Med Biol Soc (2011) 0.84
A whole of population-based series of radical prostatectomy in Victoria, 1995 to 2000. Aust N Z J Public Health (2009) 0.84
Randomised double-blind, placebo-controlled trial of coenzyme Q, therapy in class II and III systolic heart failure. Heart Lung Circ (2003) 0.83
Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouse. Diabetes (2010) 0.83
Early outcomes comparing Perfadex, Euro-Collins, and Papworth solutions in lung transplantation. Ann Thorac Surg (2006) 0.83
Techniques of reconstruction for inadequate donor left atrial cuff in lung transplantation. Ann Thorac Surg (2006) 0.82
Posttreatment quality-of-life assessment in patients with head and neck cancer treated with intensity-modulated radiation therapy. Am J Clin Oncol (2011) 0.82
A practical approach to clinical lung transplantation from a Maastricht Category III donor with cardiac death. J Heart Lung Transplant (2007) 0.82
Pathology of non-thermal irreversible electroporation (N-TIRE)-induced ablation of the canine brain. J Vet Sci (2013) 0.82
The 2005 Australian MRI safety survey. AJR Am J Roentgenol (2007) 0.82